Methods
The institutional review board of St. Joseph's Hospital and Medical Center approved this study.
Patient Population
We retrospectively reviewed the medical records and radiographic studies for all patients with histologically confirmed pineocytoma at the Barrow Neurological Institute between 1999 and 2011. The following demographic and clinical data were extracted from medical records, clinic charts, and follow-up MRI: patient age, presenting symptoms, history of prior treatment, presence of hydrocephalus, need for shunt placement, initial treatment goal (resection or biopsy), extent of resection, use of adjuvant postoperative SRS, residual tumor volume treated with radiosurgery, radiation dose, incidence of tumor progression, need for retreatment, and neurological examination, including motor and visual status, at follow-up.
Tumor Volume and Extent of Resection Calculation
The extent of resection for each case was determined by comparing MR images obtained before surgery with those obtained within 48 hours after surgery. A neurosurgeon performed a blinded, retrospective 3D volumetric analysis of pre-and postoperative MR images. Manual segmentation was performed with region-of-interest measurements of tumor volumes (in cubic centimeters) based on contrast-enhancing tissue seen on T1-weighted MR imaging. Extent of resection was calculated as follows: (preoperative tumor volume -postoperative tumor volume)/preoperative tumor volume. Volume measurements were obtained without consideration of patient outcome.
Treatment Stratification and Statistical Analysis
Each patient was retrospectively classified into one of the following 3 treatment groups: GTR, STR only, or STR with adjuvant radiosurgery (STR+SRS). Treated recurrences were also classified according to the type of treatment. The incidence of and the time to disease progression were calculated for each group. Kaplan-Meier analysis was used to generate time-to-progression curves by treatment group, and differences in time to progression were evaluated using the log-rank test with an a < 0.05 defined as statistically significant.
Results

Patient Population
Fourteen adults with newly diagnosed pineocytomas were identified, including 5 males and 9 females. The mean age at presentation was 44.2 ± 17 years (range 20-81 years). Eight patients (57%) presented with headache, 3 (21%) with nausea and vomiting, and 5 (36%) with visual disturbances. No patient presented with upgaze palsy. Three lesions (21%) were discovered incidentally. In 8 patients (57%), hydrocephalus was present at the initial presentation. Two patients (14%) had undergone prior treatment consisting of endoscopic third ventriculostomy and biopsy. No patient had undergone prior resection. Demographic and clinical characteristics of the cohort are listed in Table 1 .
Surgical Treatment
Twelve patients (86%) underwent microsurgical removal with GTR as the treatment goal, and 2 (14%) underwent endoscopic third ventriculostomy with endoscopic biopsy (Table 2 ). An SCIT approach was used in all microsurgical cases, as previously described. 7 The prone position was used in 10 of these cases (83%) and the sitting position in 2 (17%). Both endoscopic biopsies were performed via a right frontal approach. Perioperative complications were noted in 3 patients (21%): postoperative hematoma, infection, and ischemic stroke. Radiographic GTR was achieved in 5 patients (36%), and 9 patients (63%) demonstrated residual disease after treatment. Eight patients (57%) required shunt placement.
Radiosurgical Treatment
Three patients (33%) with subtotally resected tumors were treated with upfront adjuvant radiosurgery on initial presentation. Adjuvant radiosurgery was also used to treat 2 (100%) subtotally resected recurrences. All radiosurgeries were performed using a Leksell Gamma Knife and Leksell GammaPlan treatment planning software (Elekta AB). The mean radiation dose was 14.6 Gy (range 14-16 Gy) to the 50% isodose line. The median residual tumor volume treated with radiosurgery was 2.6 cm 3 (range 1.9-9.7 cm ). There were no complications associated with radiosurgery. The overall treatment strategy for each patient at initial presentation and recurrence is featured in Table 3 .
Radiographic Follow-up and Disease Progression
Eleven patients (78%) had a median MRI follow-up of 53 months (range 6-126 months). At the time of this study, 2 patients (14%) had yet to undergo surveillance imaging and 1 (7%) was lost to follow-up. No patient undergoing adjuvant radiosurgery was unaccounted for. During the follow-up period, among the 11 patients with radiographic follow-up, 3 (27%) demonstrated disease progression. The median interval to progression was 43 months (range 13-83 months). Two cases (67%) of progression required retreatment with repeat STR and adju- 2 (14) vant radiosurgery, while the third remained asymptomatic and was therefore monitored. All patients with progression had undergone STR without adjuvant radiosurgery on initial presentation. No patient who underwent GTR or STR with radiosurgery on initial presentation experienced disease recurrence or progression. The 2 cases of progression requiring repeat STR plus radiosurgery were followed up radiographically for a mean of 63.5 months after retreatment with no additional disease progression. The incidence of disease progression by treatment group, including recurrences, is featured in Fig. 1 .
Clinical Follow-up
Eleven patients (78%) were available for a median clinical follow-up of 44 months (range 1-126 months) and were evaluated with regard to motor and visual status. At the last follow-up, 8 patients (73%) remained neurologically stable as compared with their preoperative status, with no new motor or visual symptoms. One patient (9%) demonstrated neurological improvement at the follow-up, with complete resolution of the dysconjugate gaze that was present before surgery. At the last follow-up, 2 patients (18%) were neurologically worse, both with new upgaze pareses. Both patients with new deficits underwent microsurgical removal with the intention of GTR. In one of these patients GTR was achieved, whereas STR was achieved in the other. Neither deficit was attributable to radiosurgery.
Statistical Analysis
Including newly diagnosed and recurrent lesions, adjuvant radiosurgery was associated with a tumor control rate of 100% (5 of 5 patients: 2 with stable residual disease, 1 with partial remission, and 2 with complete remission) over a mean follow-up of 64.8 months. Kaplan-Meier time-to-progression curves were significantly different between the STR and STR+SRS groups (p < 0.05, log-rank test), with STR alone associated with a significantly shorter time to progression (Fig. 2) . No significant differences in time to progression existed between the STR+SRS and GTR cohorts. Subtotal resection alone was also associated with a significantly shorter time to progression as compared with GTR or STR+SRS (p < 0.05, log-rank test; Fig. 3 ).
Illustrative Cases
Case 1
A 48-year-old female presented with a 1-month history of headache, nausea, and subjective blurry vision. On admission, MRI demonstrated a 2.5 × 2.5-cm enhancing pineal region mass (Fig. 4A) . The patient, while prone, underwent an SCIT approach for microsurgical removal, and STR was achieved. Pathology confirmed pineocytoma. She did not undergo upfront adjuvant radiosurgery. Thirteen months later, she experienced worsening of her visual symptoms. Magnetic resonance imaging at that time demonstrated recurrence of the lesion (Fig. 4B) . The patient, again while prone, underwent repeat STR via an SCIT approach followed by SRS with 16 Gy to the 50% isodose line (Fig. 4C) . Follow-up MRI 112 months after retreatment demonstrated residual tumor, although it was smaller than before treatment (Fig. 4D) .
Case 2
A 37-year-old female with chronic headaches for several years presented with a 2.0 × 1.5-cm enhancing pineal mass (Fig. 5A) . She underwent an SCIT approach while prone for surgical removal of the lesion. Pineocytoma was confirmed and STR was achieved (Fig. 5B) . The patient underwent upfront adjuvant SRS with 14 Gy to the 50% isodose line. The most recent follow-up MR image at 72 months after treatment demonstrated near resolution of the lesion (Fig. 5C ).
Discussion
The infrequency of pineocytomas has prevented most efforts to establish clear evidence-based treatment paradigms. While consensus has been reached regarding the effectiveness of complete surgical removal in minimizing the risk of recurrence, 2, 3, 12 GTR is challenging and often not feasible. In cases of incompletely resected pineocytoma, the role of adjuvant radiosurgery is controversial, [4] [5] [6] with no prior studies offering a direct comparison between radiosurgery and observation for residual disease. Our results suggest that adjuvant radiosurgery reduces the risk of disease progression in cases of subtotally resected disease.
The current study represents the largest single-institution experience with multimodal treatment of pineocytomas and offers, for the first time, a direct comparison between adjuvant radiosurgery and observation alone for residual disease. We found a statistically significant decrease in the risk of progression when adjuvant radiosurgery was used to treat subtotally resected residual disease. No patient treated with adjuvant SRS experienced progression of residual disease. In both cases of progression requiring retreatment, radiosurgery following repeat STR was associated with prolonged disease control. These re- Fig. 2 . Kaplan-Meier curve showing long-term tumor control in STR and STR+SRS cohorts. There was a significantly longer (log-rank p < 0.05) progression-free interval when adjuvant radiosurgery was used to treat subtotally resected lesions. sults suggest that radiosurgery provides a benefit both as an upfront adjuvant and as a treatment for recurrence.
Prior data regarding the optimal management of residual pineocytomas are limited and conflicting. A handful of published studies have demonstrated high rates of disease control with radiosurgery as either an adjuvant or a stand-alone treatment. Hasegawa and colleagues 9 achieved 100% tumor control in 10 pineocytomas treated with biopsy or STR and adjuvant radiosurgery over a mean follow-up of 52 months. Likewise, Kobayashi and colleagues 11 demonstrated 100% tumor control in 3 pineocytoma cases receiving STR and adjuvant radiosurgery over a mean of 23.3 months. Among a series of pineal parenchymal tumors, Reyns and colleagues 16 treated 8 pineocytomas with radiosurgery as either an adjuvant or a stand-alone treatment and achieved a 100% response rate over 34 months. Other reports have demonstrated similarly high rates of tumor control with radiosurgery. 1, 8, 10, 13, 14, 17 Although these studies offer compelling evidence for the efficacy of radiosurgery, none has directly compared radiosurgery with observation for residual disease.
Although evidence supporting the efficacy of radiosurgery in treating pineocytoma is mounting, a recent disaggregated data set analysis of 64 prior pineocytoma studies, covering 166 reported patients over a 30-year period, failed to demonstrate a benefit of adjuvant radiation therapy for residual disease, both in terms of overall survival and disease progression. [4] [5] [6] Despite its comparatively large patient population, this review was limited by the heterogeneity of its database, which was compiled from case reports and small case series that varied in era, clinical setting, radiation technique, and quality. Specifically, the included studies spanned 3 decades, adhered to nonstandardized radiation regimens, and did not uniformly use SRS techniques. Appropriately, the authors noted that their study objective was to summarize the literature on pineocytomas to date. Thus, their observation that adjuvant pineocytoma radiation has no benefit in preventing disease progression was probably driven by the limitation of their methods.
In our experience, complete surgical removal and STR followed by adjuvant radiosurgery were both associated with 100% rates of long-term tumor control. It is worth noting that our study does not reflect a single standardized treatment philosophy for pineocytomas. Al- though our programmatic policy is to attempt complete resection whenever it is both safe and feasible, our results also suggest that biopsy with adjuvant radiosurgery remains an effective alternative. No complications were associated with radiosurgery. Forgoing radiosurgery after an incomplete resection was associated with a significantly shorter time to progression. In 2 of 3 cases, progression was symptomatic and required repeat surgical intervention. Although the infrequency of these tumors limits sample size, our data support a policy of postoperative adjuvant radiosurgery in cases of pineocytoma not amenable to complete resection.
Conclusions
Complete microsurgical removal remains an effective treatment for pineocytomas. However, when complete resection is not feasible, adjuvant SRS is an effective strategy to minimize the long-term risk of disease progression.
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